Ketorolac: Difference between revisions
ClaireLewis (talk | contribs) |
(Text replacement - "tx" to "treatment") |
||
| Line 8: | Line 8: | ||
**IM: 30-60 mg x 1 or 30 mg q6h | **IM: 30-60 mg x 1 or 30 mg q6h | ||
**IV: 30 mg x 1, then 15-30 mg q6h | **IV: 30 mg x 1, then 15-30 mg q6h | ||
**Black box warning against | **Black box warning against treatment for > 5 days | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 16:44, 14 July 2016
General
- Type: NSAID
- Dosage Forms: 15 mg/mL, 30 mg/mL injection
- Common Trade Names: Toradol
Adult Dosing
- Acute pain:
- IM: 30-60 mg x 1 or 30 mg q6h
- IV: 30 mg x 1, then 15-30 mg q6h
- Black box warning against treatment for > 5 days
Pediatric Dosing
- N/A
Special Populations
- Pregnancy Rating: C
- Lactation: Enters breast milk, use caution
- Elderly (> 65 yo): Decrease dose by 50%
- Renal Dosing
- Mild-Moderate impairment: Decrease dose by 50%
- Severe impairment or HD: Contraindicated
- Hepatic Dosing: No dose change, but may increase LFTs
Contraindications
- Allergy to class/drug
- Active or prior PUD, recent GI bleed
- Severe renal disease or HD
- Bleeding diathesis
Adverse Reactions
Serious
- Bleeding, MI, CVA, GI bleed/perforation, Hyperkalemia
Common
- Dispepsia, nausea, HA
Pharmacology
- Onset: 20-30 minutes
- Peak: 2-3 hours
- Duration: 4-6 hours
- Half-life: 2-6 hours, up to 19 hours in renal disease
- Metabolism: Hepatic
- Excretion: Renal
- Mechanism of Action: NSAID, Reversible COX-1/2 inhibitor
See Also
References
Lexicomp
